Age, gender and efflux transporter activity influence imatinib efficacy in chronic myeloid leukemia patients. [electronic resource]
Producer: 20200519Description: 33-35 p. digitalISSN:- 1873-5835
- ATP Binding Cassette Transporter, Subfamily B, Member 1 -- genetics
- Adult
- Age Factors
- Antineoplastic Agents -- metabolism
- B-Lymphocytes -- drug effects
- Biological Transport
- Biomarkers, Tumor -- genetics
- Female
- Humans
- Imatinib Mesylate -- metabolism
- K562 Cells
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Middle Aged
- Primary Cell Culture
- Progesterone -- pharmacology
- Proto-Oncogene Proteins c-abl -- genetics
- Sex Factors
- Treatment Outcome
No physical items for this record
Publication Type: Letter; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.